Del. Class Suit Over Weight Loss Drug Trial Leaks Tossed
A Delaware judge on Wednesday dismissed a derivative shareholder suit against Orexigen Therapeutics Inc.'s board over the publicizing of information about an unfinished obesity-drug trial, saying there was a complete failure...To view the full article, register now.
Already a subscriber? Click here to view full article